Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2014 | 05-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,553 | 0 | -2,968 | -1,143 | -1,274 |
| Depreciation Amortization | 495 | 0 | 695 | 396 | 228 |
| Other Working Capital | 182 | 0 | 2,305 | 1,763 | 1,144 |
| Other Operating Activity | 2,865 | 0 | -2,158 | -2,675 | -1,415 |
| Operating Cash Flow | $-1,012 | $0 | $-2,126 | $-1,659 | $-1,316 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | -10 | -10 | -34 |
| Investing Cash Flow | $N/A | $0 | $-10 | $-10 | $-34 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 250 | 250 | 250 |
| Debt Repayment | -108 | 0 | -156 | -125 | -93 |
| Common Stock Issued | 1,520 | 0 | 1,340 | 862 | 532 |
| Other Financing Activity | 0 | 0 | 64 | 64 | 30 |
| Financing Cash Flow | $1,413 | $0 | $1,498 | $1,051 | $719 |
| Beginning Cash Position | N/A | 0 | 638 | 638 | 638 |
| End Cash Position | 401 | 0 | N/A | 21 | 7 |
| Net Cash Flow | $401 | $0 | $-638 | $-617 | $-632 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,012 | 0 | -2,126 | -1,659 | -1,316 |
| Capital Expenditure | N/A | 0 | -10 | -10 | -34 |
| Free Cash Flow | -1,012 | 0 | -2,136 | -1,669 | -1,350 |